Genetic and Environmental Characteristics of Primary Pulmonary Hypertension

Completed

Conditions studied: Lung Diseases, Hypertension, Pulmonary

In brief

The goal of this study is to identify the modifying genes and environmental features that regulate the clinical expression of mutations in bone morphogenetic protein receptor 2 (BMPR2); to develop the understanding of how BMPR2 mutations result in disease; and to identify the undiscovered genetic mutations that cause primary pulmonary hypertension (PPH).

Key facts

Study ID

NCT00091546

Run by

Vanderbilt University

People needed

3000

Starts

2003-08-01

Expected to finish

2009-07-01

Last updated by the study team

2016-02-02

Who can join

Age: any, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of PPH, or family members of individuals diagnosed with PPH, for inclusion in the database and specimen bank

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.